Cargando…

BDNF Unveiled: Exploring Its Role in Major Depression Disorder Serotonergic Imbalance and Associated Stress Conditions

Brain-derived neurotrophic factor (BDNF) is a neurotrophin that plays a significant role in the survival and development of neurons, being involved in several diseases such as Alzheimer’s disease and major depression disorder. The association between BDNF and major depressive disorder is the subject...

Descripción completa

Detalles Bibliográficos
Autores principales:	Correia, Ana Salomé, Cardoso, Armando, Vale, Nuno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457827/ https://www.ncbi.nlm.nih.gov/pubmed/37631295 http://dx.doi.org/10.3390/pharmaceutics15082081

Ejemplares similares

Highlighting Immune System and Stress in Major Depressive Disorder, Parkinson’s, and Alzheimer’s Diseases, with a Connection with Serotonin
por: Correia, Ana Salomé, et al.
Publicado: (2021)

Exploring the Role of Drug Repurposing in Bridging the Hypoxia–Depression Connection
por: Correia, Ana Salomé, et al.
Publicado: (2023)

Oxidative Stress in Depression: The Link with the Stress Response, Neuroinflammation, Serotonin, Neurogenesis and Synaptic Plasticity
por: Correia, Ana Salomé, et al.
Publicado: (2023)

Editorial: Role of the serotonergic system in pathology of major depressive disorders
por: Norman, Trevor Ronald
Publicado: (2022)

Editorial: Role of serotonergic system in pathology of major depressive disorders
por: Fakhfouri, Gohar, et al.
Publicado: (2022)

Tryptophan Metabolism in Depression: A Narrative Review with a Focus on Serotonin and Kynurenine Pathways
por: Correia, Ana Salomé, et al.
Publicado: (2022)

BDNF rs962369 Is Associated with Major Depressive Disorder
por: Bednářová, Aneta, et al.
Publicado: (2023)

BDNF genetic variants and methylation: effects on cognition in major depressive disorder
por: Ferrer, Alex, et al.
Publicado: (2019)

BDNF Genetic Variant and Its Genotypic Fluctuation in Major Depressive Disorder
por: Ferreira Fratelli, Caroline, et al.
Publicado: (2021)

Cell Model of Depression: Reduction of Cell Stress with Mirtazapine
por: Correia, Ana Salomé, et al.
Publicado: (2022)

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Corrigendum to “Impact of serotonergic medication on interoception in major depressive disorder” [Biological Psychology 169 (2022),108286]
por: Burrows, Kaiping, et al.
Publicado: (2022)

Multi-Probiotics ameliorate Major depressive disorder and accompanying gastrointestinal syndromes via serotonergic system regulation
por: Tian, Peijun, et al.
Publicado: (2022)

BDNF Val(66)Met polymorphism and resilience in major depressive disorder: the impact of cognitive psychotherapy
por: Peters, Renata B., et al.
Publicado: (2020)

Resilience Dysregulation in Major Depressive Disorder: Focus on  Glutamatergic Imbalance and Microglial Activation
por: Réus, Gislaine Z., et al.
Publicado: (2018)

Serotonergic Modulation of Conditioned Fear
por: Homberg, Judith R.
Publicado: (2012)

Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder
por: Shkundin, Anton, et al.
Publicado: (2023)

Targeted sequencing of the BDNF gene in young Chinese Han people with major depressive disorder
por: Zhang, Chenyu, et al.
Publicado: (2020)

The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment
por: Lee, Bun-Hee, et al.
Publicado: (2010)

Comprehensive exploration of the genetic contribution of the dopaminergic and serotonergic pathways to psychiatric disorders
por: Cabana-Domínguez, Judit, et al.
Publicado: (2022)

Repurposed Edaravone, Metformin, and Perampanel as a Potential Treatment for Hypoxia–Ischemia Encephalopathy: An In Vitro Study
por: Silva, Daniela, et al.
Publicado: (2022)

Switch of serotonergic descending inhibition into facilitation by a spinal chloride imbalance in neuropathic pain
por: Aby, Franck, et al.
Publicado: (2022)

Antidepressants in Alzheimer’s Disease: A Focus on the Role of Mirtazapine
por: Correia, Ana Salomé, et al.
Publicado: (2021)

Relationship between Serotonergic Dysfunction Based on Loudness Dependence of Auditory-Evoked Potentials and Suicide in Patients with Major Depressive Disorder
por: Park, Young-Min
Publicado: (2015)

Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide
por: Youssef, Mariam M, et al.
Publicado: (2018)

Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2012)

The Effect of the Stress Induced by Hydrogen Peroxide and Corticosterone on Tryptophan Metabolism, Using Human Neuroblastoma Cell Line (SH-SY5Y)
por: Correia, Ana Salomé, et al.
Publicado: (2023)

The Combination of Serum BDNF, Cortisol and IFN-Gamma Can Assist the Diagnosis of Major Depressive Disorder
por: Chen, Suzhen, et al.
Publicado: (2021)

Role of BDNF/ProBDNF Imbalance in Postoperative Cognitive Dysfunction by Modulating Synaptic Plasticity in Aged Mice
por: Xue, Ziyi, et al.
Publicado: (2022)

Imbalance in the spinal serotonergic pathway induces aggravation of mechanical allodynia and microglial activation in carrageenan inflammation
por: Jin, Junxiu, et al.
Publicado: (2023)

Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants
por: Pehrson, Alan L, et al.
Publicado: (2015)

Correction: Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder
por: Yoshida, Taisuke, et al.
Publicado: (2013)

Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients
por: Aldoghachi, Asraa Faris, et al.
Publicado: (2019)

Epidemiological support for genetic variability at hypothalamic–pituitary–adrenal axis and serotonergic system as risk factors for major depression
por: Ching-López, Ana, et al.
Publicado: (2015)

IL-1β and BDNF are associated with improvement in hypersomnia but not insomnia following exercise in major depressive disorder
por: Rethorst, C D, et al.
Publicado: (2015)

The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study
por: Schosser, Alexandra, et al.
Publicado: (2017)

Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)
por: Mosiołek, Anna, et al.
Publicado: (2021)

Drug combination and repurposing for cancer therapy: the example of breast cancer
por: Correia, Ana Salomé, et al.
Publicado: (2021)

The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin
por: Correia, Ana Salomé, et al.
Publicado: (2023)

Serotonergic and noradrenergic function in depression: clinical correlates
por: Duval, Fabrice, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_k2q89ojgjkmts8agql0q9uhf8d